Genetic abnormalities could account for 10% to 15% of male infertility cases, so increasing attention is being paid to gene mutations in this context. DNAH1 gene polymorphisms are highly correlated with astheno-teratozoospermia, but limited information has been reported on pathogenic variations in DNAH1 in the Chinese population. We explored 4 novel variations of the DNAH1 gene in Chinese infertile patients. Mutation screening of the DNAH1 gene was performed on 87 cases of asthenozoospermia with targeted high-throughput sequencing technology; another 200 nonobstructive azoospermia cases were further analyzed to investigate the prevalence of DNAH1 variations. The effects of the variations on protein function were further assessed by bioinformatic prediction. For carriers of DNAH1 variations, genetic counseling should be considered. Assisted reproductive technologies should be performed for these individuals and microsurgery should be considered for patients with azoospermia. DNAH1 variations were identified in 6 of 287 patients. These included 8 heterozygous variations in exons and a splicing site. Among these, 4 variations (g. 52400764G>C, g. 52409336C> T, g. 52430999_52431000del, g. 52412624C> A) had already been registered in the 1000 Genomes and Exome Aggregation Consortium databases. The other 4 novel variations (g. 52418050del, g. 52404762T> G, g. 52430536del, g. 52412620del) were all predicted to be pathogenic by in silico analysis. The variations g. 52418050del and g. 52430999_ 52431000del were detected in 1 patient who was more severe than another patient with the variation g. 52430999_52431000del. Physicians should be aware of genetic variants in male infertility patients and DNAH1 mutations should be considered in patients with asthenospermia or azoospermia.
[1]Jilin Univ, Hosp 1, Ctr Reprod Med, Jilin, Jilin, Peoples R China.
[2]Jilin Univ, Hosp 1, Ctr Prenatal Diag, Jilin, Jilin, Peoples R China.
(8.0+极速模式)